PT1032390E - Formulacao anestesica - Google Patents

Formulacao anestesica

Info

Publication number
PT1032390E
PT1032390E PT98954639T PT98954639T PT1032390E PT 1032390 E PT1032390 E PT 1032390E PT 98954639 T PT98954639 T PT 98954639T PT 98954639 T PT98954639 T PT 98954639T PT 1032390 E PT1032390 E PT 1032390E
Authority
PT
Portugal
Prior art keywords
saccharide
amount
additional non
anesthetic agent
anesthetic formulation
Prior art date
Application number
PT98954639T
Other languages
English (en)
Inventor
Stephen Darwin Brown
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9724506.2A external-priority patent/GB9724506D0/en
Priority claimed from GBGB9818109.2A external-priority patent/GB9818109D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of PT1032390E publication Critical patent/PT1032390E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
PT98954639T 1997-11-19 1998-11-19 Formulacao anestesica PT1032390E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9724506.2A GB9724506D0 (en) 1997-11-19 1997-11-19 Levobupivacaine and its use
GBGB9818109.2A GB9818109D0 (en) 1998-08-19 1998-08-19 Anaesthetic Formulation

Publications (1)

Publication Number Publication Date
PT1032390E true PT1032390E (pt) 2004-04-30

Family

ID=26312628

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98954639T PT1032390E (pt) 1997-11-19 1998-11-19 Formulacao anestesica

Country Status (18)

Country Link
US (1) US5932597A (pt)
EP (1) EP1032390B1 (pt)
JP (1) JP2001522888A (pt)
KR (1) KR100695588B1 (pt)
CN (1) CN1131033C (pt)
AT (1) ATE253913T1 (pt)
AU (1) AU740914B2 (pt)
BR (1) BR9814883A (pt)
CA (1) CA2308495C (pt)
DE (1) DE69819770T2 (pt)
DK (1) DK1032390T3 (pt)
ES (1) ES2209217T3 (pt)
HK (1) HK1026848A1 (pt)
HU (1) HU228143B1 (pt)
IL (1) IL135922A0 (pt)
NO (1) NO328684B1 (pt)
PT (1) PT1032390E (pt)
WO (1) WO1999025349A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824161D0 (en) * 1998-11-04 1998-12-30 Darwin Discovery Ltd Drug formulation
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
SI1575569T1 (sl) 2002-12-13 2010-12-31 Durect Corp Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale
EP2415484B1 (en) 2004-09-17 2014-06-18 Durect Corporation Sustained local anesthetic composition containing SAIB
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
DK2117521T3 (da) 2006-11-03 2012-09-03 Durect Corp Transdermale indgivelsessystemer omfattende bupivacain
CA2706931C (en) * 2007-12-06 2015-05-12 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN105612155A (zh) * 2012-05-10 2016-05-25 塞利克斯比奥私人有限公司 治疗局部疼痛的组合物和方法
EP2983468A4 (en) 2013-03-15 2016-09-07 Durect Corp COMPOSITIONS WITH RHEOLOGY MODIFIER TO REDUCE RESOLUTION VARIABILITY
EP3331508A4 (en) * 2015-07-13 2019-06-19 Neon Laboratories Ltd. INJECTION OF HYPERBARE SOLUTION OF LEVOBUPIVACAINE HYDROCHLORIDE COMPRISING LEVOBUPIVACAINE CHLORHYDRATE
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8802564D0 (sv) * 1988-07-08 1988-07-08 Astra Ab New synergistic preparations and a new method of alleviation of pain
WO1995010277A1 (en) * 1993-10-13 1995-04-20 Chiroscience Limited Analgesic agent and its use
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use

Also Published As

Publication number Publication date
WO1999025349A1 (en) 1999-05-27
ATE253913T1 (de) 2003-11-15
EP1032390B1 (en) 2003-11-12
EP1032390A1 (en) 2000-09-06
CA2308495C (en) 2009-01-06
CN1131033C (zh) 2003-12-17
AU740914B2 (en) 2001-11-15
BR9814883A (pt) 2000-10-03
ES2209217T3 (es) 2004-06-16
KR100695588B1 (ko) 2007-03-14
US5932597A (en) 1999-08-03
IL135922A0 (en) 2001-05-20
DE69819770T2 (de) 2004-09-23
HU228143B1 (en) 2012-12-28
NO20002545D0 (no) 2000-05-18
HUP0004665A3 (en) 2004-05-28
HUP0004665A2 (hu) 2001-04-28
AU1168499A (en) 1999-06-07
KR20010032241A (ko) 2001-04-16
DE69819770D1 (de) 2003-12-18
HK1026848A1 (en) 2000-12-29
DK1032390T3 (da) 2004-03-15
CA2308495A1 (en) 1999-05-27
NO20002545L (no) 2000-05-18
JP2001522888A (ja) 2001-11-20
NO328684B1 (no) 2010-04-26
CN1279607A (zh) 2001-01-10

Similar Documents

Publication Publication Date Title
DK1032390T3 (da) Anæstetisk formulering
BR0214184A (pt) Composições que contêm óleos que possuem gravidade especìfica mais alta que a gravidade especìfica da água
FI20055562A (fi) Alfa-interferonin stabiilit vesiliuosformulaatit
BR0108828A (pt) Formulação de carboidrato (adjuvante pré-biótico) para aperfeiçoamento de resposta imuno
ZA200305412B (en) 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
BR0214264A (pt) Composição, processo de preparação da composição e seus usos
ATE179884T1 (de) Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen
ATE367097T1 (de) Verwendung von füllstoffe als sättigungsmittel
DE69931766D1 (de) Antitumorale mittel
EE03235B1 (et) Emulsioonvorm, selle valmistamise protsess ja kasutamine
CY1107649T1 (el) Συνδυασμος ο οποιος περιεχει ενα αντιφολικο αλας και παραγοντα ελαττωσης μεθυλομηλονικου οξεος
HRP20020198B1 (en) Moxifloxacin formulation containing common salt
ES2182255T3 (es) Agente de blanqueo fluorescente.
DE60104872D1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung
JP2001522888A5 (pt)
DK0666739T3 (da) Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
DK1140115T3 (da) Phospholipidkomplekser af proanthocyanidin A2 som antiatherosclerotiske midler
DE69326840T2 (de) Ophtalmische Zusammensetzungen enthaltenden Emedastine und ihre Verwendungzur Behandlung von allergischer Konjunktivitis
FI946057A (fi) Paikalliseen käyttöön tarkoitettu valmiste
DE60213464D1 (de) Amlopidinbezylat-tabletten mit verbesserter stabilität
ATE311891T1 (de) Cytidin-diphosphocholin gegen diabetische neuropathie
SE9003181D0 (sv) Use of heparin fraction
IT1256441B (it) Composizioni farmaceutiche topiche contro le punture di insetti
RU2002120345A (ru) Средство "пипользин" антигистаминного действия
TH58081B (th) สูตรใช้เฉพาะแห่งไบรวูดีนที่ได้รับการทำให้คงตัว